Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
about
Molecular epidemiology and genomics of group A StreptococcusPopulation genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombinationFunctional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence.Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.Differences in SpeB protease activity among group A streptococci associated with superficial, invasive, and autoimmune disease.Preferences for health outcomes associated with Group A Streptococcal disease and vaccination.Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Asymptomatic carriage of group A streptococcus is associated with elimination of capsule production.Disease manifestations and pathogenic mechanisms of Group A Streptococcus.Group A streptococcus expresses a trio of surface proteins containing protective epitopes.Tonsillitis and sore throat in children.Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.Protective immunogenicity of group A streptococcal M-related proteins.Virulence gene pool detected in bovine group C Streptococcus dysgalactiae subsp. dysgalactiae isolates by use of a group A S. pyogenes virulence microarrayNew 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciStreptococcus pyogenes emm Types and Clusters during a 7-Year Period (2007 to 2013) in Pharyngeal and Nonpharyngeal Pediatric Isolates.Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010.Population genomics: an investigative tool for epidemics.High Incidence of Invasive Group A Streptococcus Disease Caused by Strains of Uncommon emm Types in Thunder Bay, Ontario, Canada.Complete Genome Sequence of emm4 Streptococcus pyogenes MEW427, a Throat Isolate from a Child Meeting Clinical Criteria for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus (PANDAS).Complete Genome Sequence of emm28 Type Streptococcus pyogenes MEW123, a Streptomycin-Resistant Derivative of a Clinical Throat Isolate Suitable for Investigation of PathogenesisScarlet Fever Upsurge in England and Molecular-Genetic Analysis in North-West London, 2014.Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa.The globally disseminated M1T1 clone of group A Streptococcus evades autophagy for intracellular replication.Differences among group A streptococcus epidemiological landscapes: consequences for M protein-based vaccines?Spread of virulent group A Streptococcus type emm59 from Montana to Wyoming, USA.Group A streptococcal pharyngitis and immune-mediated complications: from diagnosis to management.Cutting edge issues in rheumatic fever.Development of Group A streptococcal vaccines: an unmet global health need.Tissue tropisms in group A Streptococcus: what virulence factors distinguish pharyngitis from impetigo strains?Prevalence of Group A beta-haemolytic Streptococcus isolated from children with acute pharyngotonsillitis in Aden, Yemen.Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.Prospective Longitudinal Analysis of Immune Responses in Pediatric Subjects After Pharyngeal Acquisition of Group A Streptococci.The emm-cluster typing system for Group A Streptococcus identifies epidemiologic similarities across the Pacific region.Potential coverage of a multivalent M protein-based group A streptococcal vaccine.Effects of pH, sodium chloride, and curing salt on the infectivity of Toxoplasma gondii tissue cysts.Added value of the emm-cluster typing system to analyze group A Streptococcus epidemiology in high-income settings.Structure-based design of broadly protective group a streptococcal M protein-based vaccines.
P2860
Q26823667-75CC2BF8-29F3-4972-ABD2-7EF77F10735BQ28750227-04EAD4CC-919A-497D-89AE-83C594D28A64Q33507907-E0860491-C9D1-4CFD-B91C-C5A3096444F5Q33674247-CBDDA066-45E4-4DCF-AFEB-8CEADBF6E7E4Q33699090-7DA1A261-2265-48B8-AF6E-DC340B24A58CQ33763940-FC778472-9517-4591-B66F-3D1C5053FD0DQ34005434-EDAAF7DE-5C03-48DF-A671-9C4A2A4E8D76Q34112608-94D6E85A-0DEC-4492-A5D5-3CE50BAE0BC7Q34298421-CAE5AD6E-475F-4B52-A578-175FEAF9C7A7Q34413457-5E9C31EA-76D8-49D7-B73A-3F4C4EDA8AEDQ34701389-394DC1F8-9A26-462D-91CD-6867BF92DA06Q34751018-0E62E23B-63D0-473C-BBBD-C9A90ABD49DCQ34971503-BA21B52F-1138-405E-8104-45518BA3895BQ34988307-5A5755A8-0DB1-4BE2-A925-4CB220250D7FQ35122760-921876ED-28D9-47D9-8266-6873BD93BEE0Q35140029-3546ADA8-0E73-42FE-95A7-10E99EDBC91DQ35376757-CE758BCF-608C-4825-8CF4-BF9DF930335DQ35757601-4ACBD8DB-4B18-410B-A9A9-E530A3E44713Q35847191-6DA65E46-963B-4A71-99EE-41F9D8691A7AQ36044610-350470CB-0CEC-416E-A278-E1419FA4098FQ36434486-D62ABC12-59E6-4847-92B4-E9F2592507B1Q36698605-A9A00914-CA59-4905-8798-0063F76CD40DQ36698618-44CE263A-0CAE-4D43-BC40-2E0906E47200Q36935283-4092679B-75F5-430E-A1D1-A8318A38CC40Q37168183-29E4A23A-B1A2-4013-A484-9A386F5650F2Q37570257-2156303D-510A-4281-8324-7DA3FA5BA17FQ37631055-A63BAC0A-0967-4A55-91D7-98E253DDF531Q37664527-806B6A6C-3236-46F2-A646-CD39FB654BD0Q37682910-E8B5D232-C9AF-42DB-AD22-377196CC5BD1Q37877594-B52EA2F6-29BC-4EE5-8A27-59B84E1EAB7FQ38631048-B15EAC5C-8674-43B6-8BA8-EE941EE4740CQ38741277-B4E30DE9-67F4-4943-BBD5-5CC429DA86ACQ39198200-E139898B-E1EF-4493-97F0-3022992A5DA7Q39829643-607A4C17-2D39-4D77-ABF9-C5397D3F83D8Q40068749-1971639C-76D8-4090-995F-80C62BCDDC3FQ40202353-996668E8-35E6-4C74-A7EC-B9780B9E0C25Q40258664-3FB14E88-CB60-4BEB-A499-538D6777EECBQ42260714-3C9074F4-6347-4F49-8EFA-5CD34F8E8329Q42998510-B7FE63CF-4682-48E5-B8C5-2BCBC2FA8A06Q47100337-E6823F9B-BA1C-4AC9-87F7-7636B983EFFF
P2860
Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Seven-year surveillance of nor ...... tococcal pharyngitis isolates.
@en
Seven-year surveillance of nor ...... tococcal pharyngitis isolates.
@nl
type
label
Seven-year surveillance of nor ...... tococcal pharyngitis isolates.
@en
Seven-year surveillance of nor ...... tococcal pharyngitis isolates.
@nl
prefLabel
Seven-year surveillance of nor ...... tococcal pharyngitis isolates.
@en
Seven-year surveillance of nor ...... tococcal pharyngitis isolates.
@nl
P2093
P356
P1476
Seven-year surveillance of nor ...... ptococcal pharyngitis isolates
@en
P2093
Bernard Beall
Devendra Patel
Emily Cederlund
Jason Rippe
Kathleen Kabat
North American Streptococcal Pharyngitis Surveillance Group
Robert R Tanz
Stanford T Shulman
Varja Sakota
William Kabat
P356
10.1086/599344
P407
P50
P577
2009-07-01T00:00:00Z